Jazz Hits Record Q3 Revenue with Strong Growth in Sleep Portfolio
Jazz Pharmaceuticals reported record third-quarter 2024 revenues of over $1.05 billion, with strong performance from its sleep portfolio.
Jazz Pharmaceuticals reported record third-quarter 2024 revenues of over $1.05 billion, with strong performance from its sleep portfolio.
Earn sleep continuing education credits (CSTEs) from Sleep Review's August/September 2024 digital edition.
Quality sleep can be hard to come by during a heat wave, especially for those who don’t have air conditioning.
A $3 million Department of Defense grant will fund University of Arizona research on using magnetic brain stimulation to address chronic insomnia in military personnel.
Movano Health has submitted a complete response package to the FDA regarding further questions on the EvieMED Ring.
Researchers conducted a national-level survey to assess the link between sleep duration, objective alertness, and psychological health in Japanese physicians, following Japan’s 2024 overtime cap.